About High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement is a rare disease catalogued by Orphanet (ORPHA:480541). It is associated with the BCL6, MYC, BCL2 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement trials.
Search ClinicalTrials.gov for "High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement" or filter by Orphanet code ORPHA:480541 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement. Updated daily.